Acticor Biotech grabs funding

Paris-based Acticor Biotech, a clinical stage biotechnology focused on thrombotic diseases, has raised 7 million euros in funding. Go Capital led the round with participation from return backers Newton BioCapital, CapDecisif Management and Anaxago.

North AmericaUSBriefs